Kolkata, Aug 21 : India's pharmaceutical sector can grow five times in the next 10 to 15 years and innovation should act as a catalyst in the growth process, a senior official said here on Friday.
Chennai, Aug 20 : Stock prices of Sun Pharmaceutical Industries Ltd flared up on Thursday against the back drop of the company getting US FDA approval for a dermatology product.
Chennai, Aug 20 : Pharmaceutical major Lupin Ltd on Thursday said it has got the USFDA approval for anti-cholesterol tablet though a sector analyst said the drug may not contribute to the company's financials majorly.
Chennai, Aug 20 : Lupin Ltd's anti-cholesterol drug securing USFDA approval is a positive development but may not contribute to the company's financials in a major way, said stock broking company Angel Broking.
Chennai, Aug 20 : Stock prices of Sun Pharmaceutical Industries Ltd flared up on Thursday on the back drop of the company getting US FDA approval for a dermatology product.
New Delhi, Aug 11 : The Delhi government on Tuesday decided to ban the sale of all blood-thinning pills like aspirin and brufen without prescription in the national capital.
Accra (Ghana), Aug 4 : The Indian pharmaceutical industry sees good prospects for growth in Africa, with the sector having quintupled in size in terms of value in just over a decade, and expected to grow to upwards of USD50 billion by 2020, according to an international consulting firm.
Mumbai, July 23 : Indian pharmaceuticals company Lupin Limited on Thursday said it has entered into a definitive agreement to acquire US-based privately-held company Gavis Pharmaceuticals LLC and Novel Laboratories Inc.
Bengaluru, July 22 : Glenmark Pharmaceuticals Limited here on Wednesday launched its advanced diabetes treatment molecule Teneligliptin under the brands Ziten and Zita plus, priced at Rs.19.90 per tablet and enough for a day's treatment.
Mumbai, July 22 : A majority of Indian pharma companies, both multinational and domestic, are yet to exploit the huge opportunities offered on various digital platforms to connect with their stakeholders effectively, a new study said on Wednesday.
Mumbai, July 20 : Drug major Sun Pharmaceutical Industries Ltd on Monday admitted that its consolidated revenue and profit for fiscal 2015-16 would be impacted by its integration with Ranbaxy Laboratories it bought for USD 3.2 billion last year.
Mumbai, July 15 : : Pharma major Pfizer Ltd announced on Wednesday the shutting down of its Thane manufacturing plant from September 16 as it has become unviable, a company spokesperson said here.
Kolkata, June 30 : MedPlus, a pharmacy retailers with over 1300 stores spread across 12 states, on Tuesday announced the launch of their innovative e-commerce service 'Click, Pick. Save.' in Kolkata.
Kolkata, June 30 : Hyderabad-based pharmacy chain, MedPlus Health Services on Tuesday said it is aiming to raise between USD60-75 million to fuel pan-India expansion plans.
Lucknow, June 29 : Apex industry body Assocham on Monday said that Uttar Pradesh was fast emerging as a cost-effective manufacturing centre for medical and dental instruments.
Bengaluru, June 29 : India's pharma major Dr Reddy's Laboratories Ltd has voluntarily recalled from the US market two medicines including one used to treat seizures like epilepsy on the advice of the regulator, an official statement said.
New Delhi, June 23 : Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.
Bengaluru, June 23 : Leading Indian drug maker Jubilant Life Sciences Tuesday announced it had received approval of the US Food and Drug Administration (FDA) for its tablets used in treating adults for various infections, including pneumonia.
New Delhi, June 23 : At USD2.5-3.1 billion, pharmaceutical outsourcing market, excluding contract manufacturing services, accounts for about 75 percent of the India's medical process outsourcing (MPO) segment, a study stated here on Tuesday.
Hyderabad, June 19 : Drug maker Dr Reddy's on Friday announced the launch of HAiROOTZ, the first hair growth supplement to be marketed in India as over-the-counter (OTC) by the company.
Bengaluru, June 11 : Indian subsidiary of British pharma major AstraZeneca on Thursday unveiled a new drug to treat Type-2 diabetes mellitus.
Kolkata, May 22 : Drug major Lupin will be replacing integrated power company, Tata Power Co Ltd in the S and P BSE Sensex from June 22.
Mumbai, May 21 : The British subsidiary of Indian drug major Cipla Ltd has acquired 51 percent equity stake in Uganda-based Quality Chemicals Ltd for USD30 million (Rs.191 crore) in tranches from its current shareholders.
Hyderabad, May 20 : The U.S. Pharmacopeial Convention (USP), a global leader in medicines quality, is bringing together national medicines control laboratory officials for a workshop on May 26-28 in Hyderabad at USP-India on improving aspects of medicines quality in the Asia-Pacific region.
New Delhi, May 13 : Drug major Lupin posted consolidated net profit of Rs.547 crore for the quarter ended March 31, 2015 compared to Rs.553 crore posted during the corresponding quarter a year back.
London, May 13 : Many fixed-dose drug combinations (FDCs) in India lack central regulatory approval despite concerns over the safety and efficacy of such combinations, say British researchers.
New Delhi /Kolkata, Apr 21 : Cirrius PharmaCRM Digital Platform on Microsoft Azure has been adopted by leading pharmaceutical companies such as Cipla, Ranbaxy and Biocon for enabling multi-channel digitization of medical engagements.
Mumbai, April 20 : The Canadian subsidiary of Mumbai-based pharmaceuticals firm Lupin Limited on Monday said it has launched its first brand product Zaxine in that country under a strategic licensing agreement.
Mumbai, March 26 : India's largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth USD 250 million (over Rs.1,500 crore) in three years.
Kolkata, March 16 : Indian pharmaceuticals companies need to diversify their product range and focus on evolving as innovators as growth in generic market is expected to slow down over the next decade, a study by industry body Assocham said on Monday.
Mumbai, March 16 : Mumbai-based drug maker Lupin on Monday said it is in the process of acquiring the balance 40 percent stake in South African generics major Pharma Dynamics (PD).
Mumbai/Kolkata, March 11 : Market regulator Securities and Exchange Board of India (SEBI) on Wednesday prohibited Kolkata-based Asoka Lifescience Ltd. (ALL) from mobilising funds through issuance of securities as well as accessing capital markets on grounds of alleged illicit fund-raising activities.
Hyderabad, Feb 28 : Pharma major Dr. Reddy's Laboratories has said that the union budget for 2015-16 has set the stage for growth in the medium to long term.
Kolkata, Feb 20 : NATCONPH 2015-National Conference on 'Empowering Pharmaceutical and Healthcare Professionals-Vision 2020' was inaugurated on Friday by Subhashish Maity, Director, NSHM Knowledge Campus (Kolkata) Group of Institutions at the Ahindra Mancha in Kolkata.
New York, Feb 20 : Scientists have designed a new type of self-healing hydrogel that could be injected through a syringe. It can be used in killing tumours, among other applications.
Bengaluru, Feb 10 : Wipro Consumer Care and Lighting Tuesday said it has secured a court order restraining Hainz India from making or selling Glucon D energy tablets.
New Delhi, Feb 3 : GlaxoSmithKline Consumer Healthcare Limited today declared its financial results for the third quarter ended December 31, 2014 where it recorded a net sales at Rs. 975 crores, a growth of 16pc over 2013.
Mumbai, Feb 3 : Pharmaceuticals-maker Lupin Tuesday said its consolidated net profit for the quarter ended Dec 31 increased by 26.32 percent to Rs.601.45 crore compared to Rs.476.13 crore for the like period in the previous fiscal.
Hyderabad, Jan 29 : Pharmaceuticals major Dr. Reddy's consolidated net profits declined by 7.09 percent due to muted growth in the US, increased in expenses and impairment charges.
New Delhi, Jan 28 : The Cabinet Committee on Economic Affairs (CCEA) Wednesday approved the proposal of drug major Lupin Ltd. to increase investment by foreign institutional investors (FIIs) to 49 percent from 33 percent.
Pittsburgh/Hyderabad, Jan 27 : Mylan Inc. on Tuesday announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816, once approved, in 91developing countries.
New Delhi, Jan 14 : The Delhi High court Wednesday issued notice to Switzerland-based Novartis AG on a plea by pharmaceutical firm Cipla, challenging a single judge bench's order that temporarily restrained it from manufacturing or selling any drug containing chemical Indacaterol, used for treating chronic respiratory disease.
New Delhi, Jan 13 : Pharmaceutical firm Cipla Tuesday moved the Delhi High Court, challenged its single judge bench's order temporarily restraining from manufacturing or selling any drug containing chemical indacaterol, used for treating chronic respiratory disease.
Mumbai, Jan 13 : The pharmaceutical solutions division of USD 750 million conglomerate Piramal Enterprises Limited (PEL) Tuesday said it is planning to invest USD 40 million on new equipment and modern technologies.
New Delhi, Jan 5 : To bring some relief to the people in the winters, Mumbai-based Pantheon PharmChem launched WARMEE, an innovative handy self-heating pouch, a company statement said here Monday.